Parkinson's Disease Research
Parkinson’s disease is a progressive neurological disorder that results when some of the nerve centers in the brain lose their ability to regulate the movement of muscles.
A person may have rigid muscles and tremors and difficulty walking and swallowing.
It is one of the most common diseases to affect movement in people over age 55. The cause is unknown, although Parkinson’s-like conditions can be seen after stroke, encephalitis, carbon monoxide or manganese poisoning, and head trauma.
Our mission is to provide the best possible treatment and care for individuals and their families that are suffering from Parkinson's Disease. We also strive to further knowledge in Parkinson's Disease and its treatment through basic and clinical research.
Current Faculty Members Involved in Research:
Mustafa Siddiqui, MD
Ihtsham Haq, MD
CURRENT CLINICAL TRIALS:
2010-Present: A study looking at molecular markers of Parkinson's Disease based on blood gene expression profiles, Investigator Initiated, Mustafa Siddiqui, MD
2011-Present: A study evaluating the treatment of Levodopa-Carbidopa intestinal gel in subjects with advanced Parkinson's Disease, Sponsor: AbbVie
2011-Present: A retrospective study of patients with movement disorders, Investigator Initiated, Mustafa Siddiqui, MD
2012-Present: fMRI hyperactivity as a predictor of impulsivity in Parkinson's disease, Investigator Initiated, Ihtsham Haq, MD
2013-Present: Deep Brain Stimulation (DBS) for the treatment of Parkinson's Disease, Sponsor: Boston Scientific Corporation
Contact Information: Sara Vaughan, BA, CCRC, email@example.com, (336) 716-8694
**Parkinson's disease study through the Department of Gerontology and Geriatric Medicine**
2013-Present: A study examing the effects of aerobic exercise for those with Parkinson's disease, Investigator Initiated, Laura Baker, MD ***Contact Information for this study is listed below***
Contact Information: Sheri Mayer, firstname.lastname@example.org, (336) 713-8520